Drugs like Ozempic and Wegovy could raise the risk of a rare form of vision loss, but we are still trying to unpick why ...

A new study adds to evidence to suggest the main ingredient in Novo Nordisk’s injectable drug for type 2 diabetes may ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

This ECG demonstrates an “extensive anterior” and “tombstoning” of the ST segment seen during a large acute anterior myocardial infarction. This is usually the result of thrombosis of the ...

Increase in NAION associated with semaglutide use among individuals with type 2 diabetes. (HealthDay News) — For individuals with type 2 diabetes (T2D), semaglutide is associated with a modestly ...

Seven of these patients developed non-arteritic anterior ischemic optic neuropathy (NAION), a condition where reduced blood flow to the optic nerve can cause sudden and irreversible blindness.

In patients with diabetes, semaglutide use was associated with an increased risk for nonarteritic anterior ischemic optic ...

The study findings suggest a possible link between semaglutide use and an increased risk of NAION in patients with diabetes.

Patients with diabetes who take semaglutide are at increased risk for NAION compared with patients who do not use GLP-1 RAs to control their blood sugar, a new study finds.

The results of this cohort study suggest that semaglutide use was associated with an increased risk of nonarteritic anterior ischemic ...